Register to McMaster Textbook today! Register today to enjoy full access to the McMaster Textbook of Internal Medicine website and mobile app.
COVID-19 chapter update The chapter discussing coronavirus disease 2019 (COVID-19) from the McMaster Textbook of Internal Medicine has just been updated to address recent changes in disease management.
A therapeutics controversy: When to take antihypertensive agents Dr Mitchell Levine from McMaster University presents recent data on timing of antihypertensive medication.
McMaster Textbook of Internal Medicine goes global! The South Asian edition of the McMaster Textbook of Internal Medicine had its official premiere in India during APICON 2022.
Virtual care and remote monitoring after post-surgery discharge Dr P.J. Devereaux and Dr Michael McGillion discuss technology use in the postsurgical setting based on SMArTVIEW and PVC-RAM-1 trial results.
Major areas to improve perioperative care and outcomes Dr Flavia Kessler Borges, Dr Sandra Ofori, and Dr Michael McGillion reflect on the key messages from the HIP ATTACK-2, PREVENT, and PVC-RAM 2 and 3 trials.
Publications of the Week, January 26 A digest of noteworthy publications curated by editors from McMaster University. This week’s focus: molnupiravir in the treatment of nonhospitalized patients with COVID-19.
Recognizing and tackling malnutrition Dr Leah Gramlich from the University of Alberta discusses evidence-based approaches to address malnutrition in hospital, at transitions of care, and in the community during the Hamilton Health Sciences Medical Rounds chaired by Dr Khalid Azzam and Dr David Armstrong.
Textbook updates New chapters and a summary of recent changes in Cardiovascular Diseases, Electrolyte, Fluid, and Acid-Base Balance Disorders, Endocrinology, Gastroenterology, Infectious Diseases, Neurology, Oncology, Signs and Symptoms.
Efpeglenatide for type 2 diabetes Dr Ally P.H. Prebtani and Dr James Douketis discuss the role of efpeglenatide, a novel GLP-1 receptor agonist, in the treatment of type 2 diabetes in patients at risk of adverse cardiovascular and renal outcomes.
English
Polski
Español
українська
русский
